• Metabolic Strategies Enhance Ferroptosis and Cuproptosis in

  2026-06-23

  The referenced study introduces a nanosystem-based metabolic intervention that synchronously sensitizes tumor cells to cuproptosis and ferroptosis. By inhibiting glycolysis and NAD+ metabolism, this approach not only heightens tumor cell vulnerability to regulated cell death but also stimulates anti-tumor immunity, offering a promising direction for advanced cancer therapies.

• Eltanexor (KPT-8602): Optimizing XPO1 Inhibition in Cancer R

  2026-06-22

  Eltanexor (KPT-8602) is reshaping cancer research by selectively targeting XPO1-mediated nuclear export, enabling robust in vitro and in vivo workflows for leukemia and colorectal cancer models. This guide details actionable protocols, troubleshooting tips, and recent advances that leverage Eltanexor’s unique mechanistic and pharmacological profile.

• Transmission Dynamics of Carbapenemase Genes in CREC, 2022–2

  2026-06-22

  This study systematically characterizes the distribution and transmission of carbapenemase-encoding genes (CEGs) in carbapenem-resistant Enterobacter cloacae (CREC) across eight teaching hospitals in Guangdong, China, during the COVID-19 era. Its findings highlight the prevalence of the blaNDM-1 gene, the efficiency of both horizontal and vertical gene transfer, and significant multidrug resistance rates, with major implications for infection control and antibiotic research.

• Primidone (Mysoline): Advanced Protocols for TRPM3 and RIPK1

  2026-06-21

  Primidone (Mysoline) is emerging as a versatile tool for TRPM3 channel and RIPK1 kinase inhibition in disease models, with validated protocols for both cellular and animal applications. This article highlights cutting-edge workflows, troubleshooting tips, and practical experimental insights that set Primidone apart as a research-grade molecule.

• Cisplatin in Cancer Research: Optimizing Apoptosis Assays an

  2026-06-20

  Harness the full experimental potential of Cisplatin (CDDP) with precise protocols for apoptosis analysis and tumor inhibition studies. Discover troubleshooting strategies, resistance mechanisms, and advanced workflows informed by cutting-edge research and APExBIO’s validated reagent quality.

• MHY1485 and the mTORC1–GCNT3 Axis: New Horizons in Cancer Re

  2026-06-19

  Explore how MHY1485, a potent mTOR activator, uniquely enables advanced dissection of the mTORC1–GCNT3 regulatory axis in cancer biology. This in-depth article reveals novel mechanistic insights and practical assay strategies for mTOR pathway and autophagy research.

• Targeting SWI/SNF ATPases in H3.3K27M Pediatric Glioma Thera

  2026-06-19

  This study demonstrates that H3.3K27M-mutant diffuse intrinsic pontine gliomas (DIPGs) exhibit upregulation of SWI/SNF ATPases and are selectively vulnerable to their targeted degradation. The findings reveal a mechanistic link between histone mutation-driven chromatin remodeling and therapeutic response, informing future strategies for pediatric brain tumor treatment.

• GTP Solution in mRNA Synthesis: Protocol Enhancements & Use-

  2026-06-18

  Unlock high-yield, contamination-free p21 mRNA synthesis for advanced bladder cancer therapy with GTP Solution (100 mM). This article delivers actionable protocol upgrades, troubleshooting insights, and applied workflows for guanosine-5'-triphosphate in mRNA-LNP research.

• Nelfinavir Mesylate: Advanced HIV-1 Protease Inhibitor Workf

  2026-06-18

  Nelfinavir Mesylate bridges potent antiretroviral action with innovative ferroptosis research, enabling precise HIV-1 protease inhibition and modulation of the DDI2-NFE2L1-UPS axis. This guide delivers hands-on protocols, troubleshooting, and experimental insights for maximizing assay reliability and translational value.

• KR-12 Peptide–Cu(II) Binding: Theoretical and Experimental I

  2026-06-17

  This study applies modern quantum chemical and calorimetric techniques to dissect how the KR-12 peptide—a minimal, non-toxic antimicrobial fragment of human LL-37—interacts with copper(II) ions. The findings improve mechanistic understanding of metal-peptide coordination, offering a foundation for rational design in bioconjugation and peptide engineering research.

• Lyso-Tracker Red: Precision Lysosome Labeling in Live Cells

  2026-06-17

  Lyso-Tracker Red DND-99 enables high-definition, live-cell lysosome visualization, surpassing traditional markers in specificity and workflow flexibility. This guide outlines optimized protocols, advanced applications, and troubleshooting insights for researchers seeking reproducible lysosomal analysis in diverse experimental settings.

• Intravesical p21 mRNA-LNP: Local Tumor Suppressor Therapy in

  2026-06-16

  This study presents a non-viral approach using chemically modified p21 mRNA encapsulated in lipid nanoparticles for targeted intravesical delivery in bladder cancer. The findings establish this method as an effective localized tumor suppressor replacement strategy, with robust preclinical efficacy and translational relevance for non–muscle-invasive disease.

• Thrombin B Chain: Strategic Leverage in Translational Resear

  2026-06-16

  Explore the central role of thrombin—a trypsin-like serine protease—in vascular biology and translational workflows. This article unpacks mechanistic insights, recent angiogenesis findings, and actionable strategies for leveraging APExBIO’s Coagulation Factor II (Thrombin) B Chain Fragment [Homo sapiens] to elevate experimental fidelity and clinical relevance across coagulation and vascular remodeling research.

• PD98059 MEK Inhibitor: Workflows for Apoptosis & Neuroprotec

  2026-06-15

  PD98059, a selective MEK inhibitor, streamlines the study of MAPK/ERK signaling in apoptosis induction and neuroprotection. Discover optimized protocols, troubleshooting strategies, and translational insights that set this tool apart for cancer and ischemia research.

• D-Lin-MC3-DMA: Ionizable Cationic Liposome for RNA Delivery

  2026-06-15

  D-Lin-MC3-DMA is a benchmark ionizable cationic liposome lipid enabling potent siRNA and mRNA delivery. It achieves superior hepatic gene silencing and facilitates endosomal escape with reduced toxicity. This article details its mechanistic advantages, literature benchmarks, and workflow integration.

456 records 14/31 page Previous Next First page 上5页 1112131415 下5页 Last page